Reducing Acute and Chronic Hypoxia in Tumours by Combining Nicotinamide with Carbogen Breathing

References

• Guichard M, Courdi A, Malaise E P. Experimental data on the radiobiology of solid tumours. Eur J Radiother 1980; 1: 171–91
   Google Scholar
• Moulder J E, Rockwell S. Hypoxic fractions of solid tumours. Int J Radiat Oncol Biol Phys 1984; 10: 695–712
   PubMedGoogle Scholar
• Overgaard J, Horsman M R. Overcoming hypoxic cell radio-resistance. Basic clinical radiobiology for radiation oncologists, G G Steel. Edward Arnold, London 1993; 163–72
   Google Scholar
• Thomlinson R H, Gray L H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955; 9: 539–49
   PubMed Web of Science ®Google Scholar
• Tannock I F. The relationship between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968; 22: 258–73
   PubMed Web of Science ®Google Scholar
• Brown J M. Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation. Br J Radiol 1979; 52: 650–6
   PubMed Web of Science ®Google Scholar
• Sutherland R M, Franko A J. On the nature of the radio-biologically hypoxic fraction in tumours. Int J Radiat Oncol Biol Phys 1980; 6: 117–20
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Durand R E, Olive P L. Acute hypoxia in tumors: implication for modifiers of radiation effects. Int J Radiat Oncol Biol Phys 1986; 12: 1279–82
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Olive P L, Durand R E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res 1987; 47: 597–601
   PubMed Web of Science ®Google Scholar
• Horsman M R. Hypoxia in tumours: Its relevance, identification and modification. Current topics in clinical radiobiology of tumours, H P Beck-Bornholdt. Springer-Verlag, Berlin 1993; 99–112
   Google Scholar
• Horsman M R, Hansen P V, Overgaard J. Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status. Int J Radiat Oncol Biol Phys 1989; 16: 1273–6
   PubMed Web of Science ®Google Scholar
• Horsman M R, Wood P J, Chaplin D J, Brown J M, Overgaard J. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. Radiother Oncol 1990; 18: 49–57
   PubMed Web of Science ®Google Scholar
• Horsman M R, Chaplin D J, Overgaard J. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells. Cancer Res 1990; 50: 7430–6
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Horsman M R, Trotter M J. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J Natl Cancer Inst 1990; 82: 672–6
   PubMedGoogle Scholar
• Chaplin D J, Horsman M R, Aoki D. Nicotinamide, fluosol DA and carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 1991; 63: 109–13
   PubMed Web of Science ®Google Scholar
• Kjellen E, Joiner M C, Collier J M, Johns H, Rojas A. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol 1991; 22: 81–91
   PubMed Web of Science ®Google Scholar
• Chaplin D J, Horsman M R, Siemann D W. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate acutely and chronically hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. Br J Cancer 1993; 68: 269–73
   PubMed Web of Science ®Google Scholar
• Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys 1980; 6: 1507–17
   PubMed Web of Science ®Google Scholar
• Trotter M J, Chaplin D J, Durand R E, Olive P L. The use of fluorescent probes to identify regions of transient perfusion in murine tumours. Int J Radiat Oncol Biol Phys 1989; 16: 931–4
   PubMed Web of Science ®Google Scholar
• Horsman M R, Høyer M, Honess D J, Dennis I F, Overgaard J. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother Oncol 1993; 27: 131–9
   PubMed Web of Science ®Google Scholar
• Horsman M R, Siemann D W, Nordsmark M, Khalil A A, Overgaard J, Chaplin D J. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. Adv Exper Med Biol 1994, in press
   Google Scholar
• Grau C, Horsman M R, Overgaard J. Improving the radiation response in a C3H mouse mammary carcinoma by normo-baric oxygen or carbogen breathing. Int J Radiat Oncol Biol Phys 1992; 22: 415–9
   PubMedGoogle Scholar
• Siemann D W, Hill R P, Bush R A. The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2; 95% O2) on the in vivo radiation response of a murine sarcoma. Int J Radiat Oncol Bioi Phys 1977; 2: 903–11
   PubMed Web of Science ®Google Scholar
• Siemann D W, Horsman M R, Chaplin D J. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiother Oncol 1994; 31: 117–22
   PubMed Web of Science ®Google Scholar
• Lee I., Song C W. The oxygenation of murine isografts and human tumour xenografts by nicotinamide. Radiat Res 1992; 130: 65–71
   PubMed Web of Science ®Google Scholar
• Kelleher D K, Vaupel P W. Nicotinamide exerts apparently opposing acute effects on microcirculatory function and tissue oxygenation in rat tumours. Int J Radiat Oncol Biol Phys 1993; 26: 95–102
   PubMed Web of Science ®Google Scholar
• Horsman M R, Nordsmark M, Khalil A, Chaplin D J, Overgaard J. Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?. Adv Exper Med Biol, in press
   Google Scholar
• Horsman M R, Kristjansen P EG, Mizumo M. Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice. Int J Radiat Oncol Biol Phys 1992; 22: 451–4
   PubMedGoogle Scholar
• Wood P J, Counsell C JR, Bremner J CM, Horsman M R, Adams G E. The measurement of radiosensitizer-induced changes in mouse tumour metabolism by 31-P magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 1991; 20: 291–4
   PubMedGoogle Scholar
• Horsman M R, Chaplin D J, Browm J M. Tumor radiosensitization by nicotinamide: a result of improved blood perfusion and oxygenation. Radiat Res 1989; 118: 139–50
   PubMed Web of Science ®Google Scholar
• Horsman M R, Brown J M, Hirst V K. Mechanism of action of the selective tumour radiosensitizer nicotinamide. Int J Radiat Oncol Biol Phys 1988; 15: 685–90
   PubMed Web of Science ®Google Scholar
• Hees P S, Sotak C H. Assessment of changes in murine tumour oxygenation in response ot nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion. Magn Reson Med 1993; 29: 303–10
   PubMedGoogle Scholar
• Zackheim H S, Vasily D B, Westphal M L, Hastings C W. Reactions to niacinamide. J Am Acad Dermatol 1981; 4: 736–7
   PubMed Web of Science ®Google Scholar
• Rubin P, Hanley J, Keys H M, Marcial V, Brady L. Carbogen breathing during radiation therapy. The radiation therapy oncology group study. Int J Radiat Oncol Biol Phys 1979; 5: 1963–70
   PubMed Web of Science ®Google Scholar
• Suit H D, Marshall N, Woerner D. Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma. Cancer 1972; 30: 1154–8
   PubMed Web of Science ®Google Scholar